ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pyrogallol promotes growth arrest by activating the p53-mediated up-regulation of p21 and p62/SQSTM1-dependent degradation of β-catenin in nonsmall cell lung cancer cells

Zhou, Beixian; Wang, Linxin; Ren, Zhixian; Liang, Yueyun; Yang, Sushan; Zhang, Yuehan; Che, Siyao*; Fang, Weiyi*南方医科大学; 云南大学
Environmental Toxicology2023-12-18DOI: 10.1002/tox.24099
12阅读
引用收藏
分享

摘要

Pyrogallol (1,2,3-trihydroxybenzene), a polyphenolic natural compound, has attracted considerable attention with regard to its potential anticancer activity. However, further study is needed to elucidate the underlying mechanism related to the antiNSCLC activity of pyrogallol and provide a comprehensive theoretical basis for better clinical utilization of pyrogallol. Our current study aims to investigate the effects and potential underlying mechanisms of pyrogallol on the inhibition of NSCLC growth. Our results showed that pyrogallol treatment induced cell cycle arrest at the G2/M phase and apoptosis in two different NSCLC cell lines. Mechanistically, we found that the induction of cell cycle arrest in NSCLC cells at the G2/M phase by pyrogallol was due to the upregulation of p21 in a p53-dependent manner. And blockade of p53 and p21 effectively abolished the cell cycle arrest at the G2/M phase. Meanwhile, p53 inhibition has been found to abrogate the pyrogallol-induced apoptosis of the two NSCLC cells. Moreover, we revealed that the inhibitory effects of pyrogallol on beta-catenin signaling resulted from autophagy initiation depending on p53 activation, accompanied by an increase in p62/SQSTM1 expression, thus p62 subsequently interacting with ubiquitinated beta-catenin and facilitating autophagic destruction of beta-catenin. Furthermore, in vivo experiments demonstrated that pyrogallol exerted growth inhibition on NSCLC with low toxicity through the same molecular mechanism as observed in vitro. Our findings could contribute to the understanding of the mechanism by which pyrogallol negatively regulates NSCLC growth, which could be effective in treating NSCLC.

学科与关键词

关键词
autophagynonsmall cell lung cancer cellsp53pyrogallolubiquitination
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Environmental Toxicology
发表日期
2023-12-18
DOI
10.1002/tox.24099
语言
ENGLISH
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation

作者

  • Z

    Zhou, Beixian (第一作者)

    southern med univ

  • W

    Wang, Linxin

    southern med univ

查看全部 8 位作者收起作者
  • R

    Ren, Zhixian

    yunnan univ

  • L

    Liang, Yueyun

  • Y

    Yang, Sushan

  • Z

    Zhang, Yuehan

  • C

    Che, Siyao (通讯)

  • F

    Fang, Weiyi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417